Cargando…
Pharmaceutical Industry in Syria
The aim of this article is to present the development of the pharmaceutical industry in Syria using national and international public data sources. At the end of the 80ies, the pharmaceutical industry in Syria was very poor, covering 6% of the national needs. In less than 20 years, with the governme...
Autor principal: | |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
Carol Davila University Press
2010
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3018990/ https://www.ncbi.nlm.nih.gov/pubmed/20945828 |
_version_ | 1782196138009427968 |
---|---|
author | Kutaini, D |
author_facet | Kutaini, D |
author_sort | Kutaini, D |
collection | PubMed |
description | The aim of this article is to present the development of the pharmaceutical industry in Syria using national and international public data sources. At the end of the 80ies, the pharmaceutical industry in Syria was very poor, covering 6% of the national needs. In less than 20 years, with the government support in terms of legal frame and strategic political engagement, the Syrian pharmaceutical industry finally covered almost 90% of the national needs, in terms of drugs, and exported drugs in around 52 Arabian countries. Beyond covering the local market, the main added values of this huge development consisted in exporting drugs in amount of 150 million dollars per year and providing jobs for 17000 Syrian people, out of which around 85% are women. Strong and weak points of the pharmaceutical sector are taken into consideration in the article and further interventions to support a sustainable development are proposed by the author. |
format | Text |
id | pubmed-3018990 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2010 |
publisher | Carol Davila University Press |
record_format | MEDLINE/PubMed |
spelling | pubmed-30189902011-03-03 Pharmaceutical Industry in Syria Kutaini, D J Med Life Student Message Board The aim of this article is to present the development of the pharmaceutical industry in Syria using national and international public data sources. At the end of the 80ies, the pharmaceutical industry in Syria was very poor, covering 6% of the national needs. In less than 20 years, with the government support in terms of legal frame and strategic political engagement, the Syrian pharmaceutical industry finally covered almost 90% of the national needs, in terms of drugs, and exported drugs in around 52 Arabian countries. Beyond covering the local market, the main added values of this huge development consisted in exporting drugs in amount of 150 million dollars per year and providing jobs for 17000 Syrian people, out of which around 85% are women. Strong and weak points of the pharmaceutical sector are taken into consideration in the article and further interventions to support a sustainable development are proposed by the author. Carol Davila University Press 2010-08-15 2010-08-25 /pmc/articles/PMC3018990/ /pubmed/20945828 Text en ©Carol Davila University Press http://creativecommons.org/licenses/by/2.0/ This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. |
spellingShingle | Student Message Board Kutaini, D Pharmaceutical Industry in Syria |
title | Pharmaceutical Industry in Syria
|
title_full | Pharmaceutical Industry in Syria
|
title_fullStr | Pharmaceutical Industry in Syria
|
title_full_unstemmed | Pharmaceutical Industry in Syria
|
title_short | Pharmaceutical Industry in Syria
|
title_sort | pharmaceutical industry in syria |
topic | Student Message Board |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3018990/ https://www.ncbi.nlm.nih.gov/pubmed/20945828 |
work_keys_str_mv | AT kutainid pharmaceuticalindustryinsyria |